Cannabis Stocks Sink Following Pause in DEA Rescheduling Hearing

Key Facts

Cannabis stocks declined following a pause in the DEA hearing regarding the rescheduling of marijuana. Seeking Alpha reported that the sell-off occurred after a procedural stay was issued in the proceedings aimed at potentially moving marijuana from Schedule I to Schedule III status.

The pause in the regulatory hearing triggered a negative price reaction across the sector, particularly affecting multi-state operators. This uncertainty regarding the timeline and likelihood of federal marijuana reform prompted investors to reduce risk exposure in the policy-sensitive cannabis industry.